Pharma Q2 Outlook: Pricing pressure, US competition to weigh on select players
Sun Pharmaceutical moved higher in a quarterly results development.
· Economic Times Markets, ET Stocks
India's pharmaceutical companies are expected to have a mixed performance in the upcoming September quarter. Companies like Sun Pharmaceutical Industries and Aurobindo Pharma are likely to report good growth. In contrast, Dr Reddy's Laboratories and Lupin may face challenges due to increased competition and a high base.
The analysis
Against that, the stock is +0.9% on the day at ₹1,777.70, and has returned -11.2% over three months. It sits 11% below its 52-week high. The pharma & healthcare sector has moved -0.9% over the same period, so Sun Pharmaceutical is running 10.3 points behind its peers.
With Sun Pharmaceutical, Aurobindo Pharma and Dr Reddy all implicated, this reads as a Pharma & Healthcare-level move rather than a company-specific one, which is the more durable kind of signal.
Why it matters
- Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
Market context
- 3 of the 3 companies named are in Pharma & Healthcare, so the story reads across that sector rather than for one company.
- On the day, 3 of 3 are higher: Aurobindo Pharma leads at +1.3% and Dr Reddy trails at +0.5%.
- Over three months: Sun Pharmaceutical -11.2% against Pharma & Healthcare -0.9% (10.3 points behind); Aurobindo Pharma +6.7% against Pharma & Healthcare -0.9% (7.6 points ahead); Dr Reddy +18.1% against Pharma & Healthcare -0.9% (19.0 points ahead).
- Trading well above normal today: Sun Pharmaceutical at 3.4 times its 20-day average volume.
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Sun PharmaceuticalSUNPHARMA · Pharma & Healthcare | ₹1,777.70 | +0.9% | -2.1% | -11.2% | -11.2% | 3.4× | — |
| Aurobindo PharmaAUROPHARMA · Pharma & Healthcare | ₹1,681.40 | +1.3% | +0.6% | +6.7% | -3.0% | 1.2× | — |
| Dr ReddyDRREDDY · Pharma & Healthcare | ₹1,352.00 | +0.5% | +9.7% | +18.1% | -1.7% | 0.8× | — |
Pharma & Healthcare
1M -0.6% · 3M -0.9%
Sun Pharmaceutical, Aurobindo Pharma, Dr Reddy
Prices as of 30 Oct 2026, 16:11 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Q2 Results Live: Varun Beverages Q3 Net Profit Rises 14% YoY; Reliance Slips, Sun Pharma Gains Ahead Of Earnings
Nifty Pharma index hits record high; Sun, Laurus, Zydus, Sai rally up to 6%
Max Healthcare Q2 PAT rises 10% to ₹448 cr on higher bed occupancy
Laurus Labs shares climb 4% after Q2 profit zooms 126% YoY
Laurus Labs Q2 Review: Brokerages Split As Jefferies Raises Target, Two Retain Sell